Cargando…
Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells
Chemotherapy resistance is an obstacle to cancer therapy and is considered a major cause of recurrence. Thus, understanding the mechanisms of chemoresistance is critical to improving the prognosis of patients. Here, we have established a stepwise gemcitabine-resistant T24 bladder cancer cell line to...
Autores principales: | Mun, Jeong-Yeon, Baek, Seung-Woo, Jeong, Mi-So, Jang, In-Hwan, Lee, Se-Ra, You, Jae-Young, Kim, Jeong-Ah, Yang, Gi-Eun, Choi, Yung-Hyun, Kim, Tae-Nam, Chu, In-Sun, Leem, Sun-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640638/ https://www.ncbi.nlm.nih.gov/pubmed/36344487 http://dx.doi.org/10.1038/s41420-022-01242-8 |
Ejemplares similares
-
YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer
por: Baek, Seung-Woo, et al.
Publicado: (2022) -
VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer
por: Kim, Min-Hye, et al.
Publicado: (2021) -
Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance
por: Roh, Yun-Gil, et al.
Publicado: (2020) -
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
por: Roh, Yun-Gil, et al.
Publicado: (2018) -
E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair
por: Mun, Jeong-Yeon, et al.
Publicado: (2020)